Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CHEMPARTNER EUROPE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4%   Bankruptcy risk   4.7% 2.0% 3.3% 3.3% 4.7% 4.7% 9.4% 9.4%   Credit score (0-100)   47 70 55 53 45 45 26 26   Credit rating   BBB A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,320 7,420 5,444 6,046 6,643 9,187 0.0 0.0   EBITDA   497 3,131 442 640 554 -1,371 0.0 0.0   EBIT   489 3,131 442 640 554 -1,371 0.0 0.0   Pre-tax profit (PTP)   427.8 3,026.0 1,064.6 2,482.0 696.3 61.4 0.0 0.0   Net earnings   332.7 2,355.2 772.1 1,982.9 548.2 47.9 0.0 0.0   Pre-tax profit without non-rec. items   428 3,026 1,065 2,482 696 61.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   3,290 5,645 6,417 8,400 2,486 2,533 2,408 2,408   Interest-bearing liabilities   9,447 4,331 11,232 9,376 30,380 11,655 0.0 0.0   Balance sheet total (assets)   13,645 10,749 18,768 18,552 33,145 14,793 2,408 2,408   Net Debt   2,084 -3,290 4,607 6,303 19,302 7,541 -2,408 -2,408     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,320 7,420 5,444 6,046 6,643 9,187 0.0 0.0   Gross profit growth   -21.8% 123.5% -26.6% 11.1% 9.9% 38.3% -100.0% 0.0%   Employees   3 3 5 5 5 6 0 0   Employee growth %   50.0% 0.0% 66.7% 0.0% 0.0% 20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   13,645 10,749 18,768 18,552 33,145 14,793 2,408 2,408   Balance sheet change%   2.8% -21.2% 74.6% -1.2% 78.7% -55.4% -83.7% 0.0%   Added value   496.6 3,130.7 441.9 640.3 554.2 -1,371.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -15 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.7% 42.2% 8.1% 10.6% 8.3% -14.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.6% 25.7% 7.5% 13.7% 2.8% 0.3% 0.0% 0.0%   ROI %   3.9% 27.6% 8.0% 14.5% 2.8% 0.3% 0.0% 0.0%   ROE %   10.7% 52.7% 12.8% 26.8% 10.1% 1.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   24.1% 52.5% 34.2% 45.3% 7.5% 17.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   419.8% -105.1% 1,042.6% 984.5% 3,483.1% -549.8% 0.0% 0.0%   Gearing %   287.1% 76.7% 175.0% 111.6% 1,222.2% 460.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.6% 1.5% 0.5% 0.8% 0.1% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 2.1 1.5 1.8 1.1 1.2 0.0 0.0   Current Ratio   1.3 2.1 1.5 1.8 1.1 1.2 0.0 0.0   Cash and cash equivalent   7,362.7 7,620.8 6,625.3 3,072.2 11,077.7 4,114.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,290.0 5,645.1 6,417.2 8,400.1 2,485.5 2,533.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   166 1,044 88 128 111 -229 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   166 1,044 88 128 111 -229 0 0   EBIT / employee   163 1,044 88 128 111 -229 0 0   Net earnings / employee   111 785 154 397 110 8 0 0